Vice President - Investment Banking

Salary Range: 165000 to 165000 (Currency: USD) (Pay period: per-year-salary)

About the Role

LifeSci Capital is seeking a Vice President to join its Investment Banking team. The Vice President will lead the execution of equity and M&A transactions for biotechnology and life sciences clients, ranging from private companies preparing to access the public markets through newly public and small- and mid-cap issuers.

This is a senior execution and client-facing role. The Vice President sits between the senior bankers and the analyst and associate bench, owning transaction workstreams end to end, serving as a day-to-day point of contact for client management teams, and contributing directly to new business development. Because the team is lean, the Vice President will carry a level of client ownership and deal responsibility that would typically sit a title above at a larger institution, with a clear path toward Managing Director.

Key Responsibilities

Transaction Execution

Lead day-to-day execution of capital markets and M&A transactions, including IPOs, follow-on offerings, PIPEs, registered directs, ATM programs, convertible notes, and structured financings.

Own the development and review of financial models, valuation analyses, and strategic analyses, including risk-adjusted NPV, probability-of-success weighting, comparable company and precedent transaction analysis, and dilution and capitalization scenarios for pre-revenue issuers.

Manage transactions from pitch and marketing through diligence, negotiation, and closing, coordinating internal teams, outside counsel, auditors, and other advisors to keep processes on schedule.

Lead business and financial due diligence, identify transaction and disclosure risks, and develop mitigation strategies in coordination with senior bankers and counsel.

Conduct company, therapeutic area, and market research to support transaction execution, positioning, and new business development.

Marketing and Business Development

Direct the development of client-facing materials, including pitch books, management presentations, confidential information memoranda, and offering marketing materials.

Develop transaction narratives that translate clinical, regulatory, and commercial data into a differentiated equity story for institutional investors.

Support new business generation through origination analyses, market monitoring, and preparation for and participation in pitches.

Build and maintain relationships with clients, prospective clients, healthcare-dedicated institutional investors, and professional advisors across the sector, including through industry conferences and corporate access events.

Collaborate with colleagues across the LifeSci Partners platform to identify opportunities and deliver integrated support to clients.

Client Management

Serve as a day-to-day point of contact for client management teams, presenting analyses and recommendations clearly to CEOs, CFOs, and boards.

Communicate transaction status, key issues, and client interactions to senior bankers and firm management.

Exercise sound judgment and discretion when handling material non-public information and working with senior executives.

Team Leadership and Development

Lead deal teams of analysts and associates: set direction and expectations, review work product, and provide timely, constructive feedback.

Mentor and develop junior bankers, building both technical capability and sector fluency.

Contribute to recruiting, training, and the ongoing development of team processes and standards.

Qualifications

Transaction Experience

Five or more years of investment banking or closely related transaction experience; candidates with an advanced degree may be considered with fewer years of relevant experience.

Demonstrated experience executing equity and equity-linked transactions, with live deal experience in a healthcare or life sciences coverage or capital markets group strongly preferred.

Proven ability to manage transactions across the full lifecycle, including pitching, marketing, diligence, valuation, execution, and closing.

Strong command of accounting, financial modeling, valuation methodologies, and transaction structures.

Sector and Scientific Fluency

Meaningful transaction experience in biotechnology and pharmaceuticals, with a demonstrated commitment to the sector.

Ability to read and interpret clinical trial data and to discuss development stage, mechanism of action, regulatory pathway, competitive landscape, and commercial opportunity credibly with management teams and investors.

Familiarity with the healthcare-dedicated and crossover investor base and with how pre-commercial biotechnology companies are valued and financed.

Analytical and Communication Skills

Exceptional quantitative and analytical capability, with the ability to translate complex financial and scientific information into clear, actionable conclusions.

Exceptional written and verbal communication skills, including comfort presenting to senior executives and boards.

Strong attention to detail and the ability to manage multiple live transactions and competing priorities.

Professional Qualities

Sound judgment, maturity, integrity, and discretion.

Demonstrated ability to operate effectively in an entrepreneurial, unstructured environment and to independently identify and solve problems.

Collaborative approach and a commitment to building a high-performing team culture.

Education and Licensing

Bachelor’s degree from an accredited institution with a strong academic record. Coursework or concentration in finance, accounting, economics, mathematics, engineering, or the life sciences is preferred.

An advanced degree (MBA, MS, PhD, MD, PharmD, or comparable) is a plus, particularly in a life sciences discipline.

Series 79 and Series 63 licenses required; candidates who are not currently registered must obtain both within 120 days of hire.

Benefits

Comprehensive healthcare benefits with low-cost employee contribution
Generous PTO policy
401(k) plan
Paid Parental Leave
Commuter benefits & additional EOP offerings